These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9517374)
1. Molecular effects of sulphonylurea agents in circulating lymphocytes of patients with non-insulin-dependent diabetes mellitus. Rabbone I; Piccinini M; Curto M; Mostert M; Gamba S; Mioletti S; Bruno R; Rinaudo MT Br J Clin Pharmacol; 1998 Mar; 45(3):291-9. PubMed ID: 9517374 [TBL] [Abstract][Full Text] [Related]
2. Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM). Rinaudo MT; Curto M; Rabbone I; Piccinini M; Bruno R; Mioletti S; Gamba S J Diabetes Complications; 1994; 8(4):221-5. PubMed ID: 7833497 [TBL] [Abstract][Full Text] [Related]
3. Insulin resistance in obese subjects and newly diagnosed NIDDM patients and derangements of pyruvate dehydrogenase in their circulating lymphocytes. Curto M; Novi RF; Rabbone I; Maurino M; Piccinini M; Mioletti S; Mostert M; Bruno R; Rinaudo MT Int J Obes Relat Metab Disord; 1997 Dec; 21(12):1137-42. PubMed ID: 9426381 [TBL] [Abstract][Full Text] [Related]
4. Derangements of pyruvate dehydrogenase in circulating lymphocytes of NIDDM patients and their healthy offspring. Mostert M; Rabbone I; Piccinini M; Curto M; Vai S; Musso A; Rinaudo MT J Endocrinol Invest; 1999; 22(7):519-26. PubMed ID: 10475149 [TBL] [Abstract][Full Text] [Related]
5. G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes. Curto M; Piccinini M; Rabbone I; Mioletti S; Mostert M; Bruno R; Rinaudo MT Int J Biochem Cell Biol; 1997 Oct; 29(10):1207-17. PubMed ID: 9438382 [TBL] [Abstract][Full Text] [Related]
6. In obese individuals dexfenfluramine corrects molecular derangements reflecting insulin resistance. Piccinini M; Rabbone I; Novi RF; Alberto G; Mostert M; Musso A; Vai S; Gamba S; Rinaudo MT Int J Obes Relat Metab Disord; 2000 Jun; 24(6):735-41. PubMed ID: 10878680 [TBL] [Abstract][Full Text] [Related]
8. Effects of insulin on pyruvate dehydrogenase in circulating lymphocytes from normal and diabetic rats. Rinaudo MT; Curto M; Bruno R; Marino C; Mostert M Int J Biochem; 1988; 20(7):667-74. PubMed ID: 3053285 [TBL] [Abstract][Full Text] [Related]
9. The insulin signal and its effects on the pyruvate dehydrogenase complex in circulating lymphocytes of obese children. Curto M; Piccinini M; Cerutti F; Rabbone I; Mostert M; Sacchetti C; Bruno R; Rinaudo MT Int J Biochem; 1992 May; 24(5):831-7. PubMed ID: 1592161 [TBL] [Abstract][Full Text] [Related]
10. Insulin modulation of pyruvate dehydrogenase in human circulating lymphocytes. Curto M; Piccinini M; Bruno R; Mostert M; Rinaudo MT Int J Biochem; 1988; 20(11):1211-7. PubMed ID: 3073980 [TBL] [Abstract][Full Text] [Related]
11. Sensitivity of pyruvate dehydrogenase to insulin in activated T lymphocytes. Lack of responsiveness to insulin in patients with polycystic ovarian disease and diabetes. Buffington CK; Givens JR; Kitabchi AE Diabetes; 1990 Mar; 39(3):361-8. PubMed ID: 2407584 [TBL] [Abstract][Full Text] [Related]
12. Gliclazide potentiates suppression of hepatic glucose production in non-insulin-dependent diabetic patients. Riccio A; Lisato G; de Kreutzenberg SV; Marchetto S; Turrin M; Tiengo A; Del Prato S Metabolism; 1996 Oct; 45(10):1196-202. PubMed ID: 8843172 [TBL] [Abstract][Full Text] [Related]
13. Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus. Palmer KJ; Brogden RN Drugs; 1993 Jul; 46(1):92-125. PubMed ID: 7691511 [TBL] [Abstract][Full Text] [Related]
14. The behaviour of pyruvate dehydrogenase in circulating lymphocytes from diabetic children. Rinaudo MT; Curto M; Bruno R; Marino C; Piccinini M; Cerutti F; Mostert M; Sacchetti C Diabetologia; 1989 Apr; 32(4):245-8. PubMed ID: 2668078 [TBL] [Abstract][Full Text] [Related]
15. Pyruvate dehydrogenase activity is stimulated by growth hormone (GH) in human mononuclear cells: a new tool to measure GH responsiveness in man. Clot JP; Benelli C; Fouque F; Bernard R; Durand D; Postel-Vinay MC J Clin Endocrinol Metab; 1992 Jun; 74(6):1258-62. PubMed ID: 1592868 [TBL] [Abstract][Full Text] [Related]
16. Genetic cause of hyperglycaemia and response to treatment in diabetes. Pearson ER; Starkey BJ; Powell RJ; Gribble FM; Clark PM; Hattersley AT Lancet; 2003 Oct; 362(9392):1275-81. PubMed ID: 14575972 [TBL] [Abstract][Full Text] [Related]
17. Adipocyte glycogen synthase and pyruvate dehydrogenase in obese and type II diabetic subjects. Mandarino LJ; Madar Z; Kolterman OG; Bell JM; Olefsky JM Am J Physiol; 1986 Oct; 251(4 Pt 1):E489-96. PubMed ID: 3094377 [TBL] [Abstract][Full Text] [Related]
18. Effects of exposure of human islet beta-cells to normal and high glucose levels with or without gliclazide or glibenclamide. Del Guerra S; D'Aleo V; Lupi R; Masini M; Bugliani M; Boggi U; Filipponi F; Marchetti P Diabetes Metab; 2009 Sep; 35(4):293-8. PubMed ID: 19502091 [TBL] [Abstract][Full Text] [Related]
19. Diet only or diet and sulfonylureas in mild type II diabetes (NIDDM)? Pathophysiologic and therapeutic implications. Sinay IR; Arias P; Schnitman MA; Damilano SA; Faingold MC; Moguilevsky JA Acta Diabetol Lat; 1988; 25(4):289-97. PubMed ID: 3072813 [TBL] [Abstract][Full Text] [Related]